Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BURLINGTON › LAHEY CLINIC HOSPITAL, INC.

LAHEY CLINIC HOSPITAL, INC.

NPI: 1558392563 · BURLINGTON, MA 01805 · General Acute Care Hospital · NPI assigned 07/06/2006

$112.94M
Total Medicaid Paid
3,168,326
Total Claims
2,727,201
Beneficiaries
592
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLONGWORTH, DAVID (CEO)
NPI Enumeration Date07/06/2006

Related Entities

Other providers sharing the same authorized official: LONGWORTH, DAVID

ProviderCityStateTotal Paid
LAHEY CLINIC HOSPITAL INC PEABODY MA $42K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 453,781 $15.70M
2019 497,579 $16.73M
2020 405,217 $13.79M
2021 506,349 $18.32M
2022 504,708 $19.35M
2023 454,281 $17.47M
2024 346,411 $11.58M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 90,799 77,670 $12.00M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 57,705 51,172 $7.01M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 39,731 35,667 $6.32M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 198,210 141,891 $5.34M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 30,133 26,666 $4.66M
99215 Prolong outpt/office vis 35,731 32,801 $4.56M
96361 Intravenous infusion, hydration; each additional hour 13,779 12,150 $4.35M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 33,620 29,375 $4.05M
99284 Emergency department visit for the evaluation and management, high severity 23,955 22,081 $3.51M
99283 Emergency department visit for the evaluation and management, moderate severity 21,446 19,802 $2.98M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 36,286 13,876 $2.11M
J0585 Injection, onabotulinumtoxina, 1 unit 5,137 3,211 $2.07M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 2,306 2,255 $1.76M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 3,086 2,976 $1.69M
45380 Colonoscopy, flexible; with biopsy, single or multiple 2,121 2,073 $1.61M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 28,281 26,042 $1.59M
74177 Computed tomography, abdomen and pelvis; with contrast material 11,408 10,578 $1.32M
20610 7,984 7,029 $1.26M
70450 Computed tomography, head or brain; without contrast material 10,972 9,998 $1.14M
78815 Positron emission tomography (PET) for limited area imaging 1,560 1,467 $1.13M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 5,235 3,584 $1.12M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 4,285 4,085 $1.10M
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 9,665 9,449 $1.07M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 6,463 6,145 $1.01M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 10,766 10,431 $875K
62323 2,306 2,232 $852K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 22,278 8,447 $789K
77063 Screening digital breast tomosynthesis, bilateral 12,279 12,124 $771K
74183 3,095 2,935 $723K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 5,699 5,604 $652K
67028 Intravitreal injection of a pharmacologic agent 4,604 4,233 $643K
43235 971 939 $632K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 6,379 6,101 $629K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,587 4,304 $597K
11102 1,242 1,167 $568K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 17,500 15,128 $568K
64615 2,115 2,016 $554K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 4,323 4,179 $539K
80053 Comprehensive metabolic panel 107,955 93,438 $471K
76700 Ultrasound, abdominal, real time with image documentation; complete 3,627 3,484 $469K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 27,718 26,914 $467K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4,861 4,399 $437K
76705 Ultrasound, abdominal, real time with image documentation; limited 4,562 4,333 $434K
96415 2,022 1,516 $425K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,868 3,876 $425K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 109,505 91,983 $416K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 2,593 2,464 $411K
95806 502 501 $411K
74176 Computed tomography, abdomen and pelvis; without contrast material 3,534 3,331 $404K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 12,942 11,468 $387K
93971 3,256 3,013 $378K
93975 4,193 3,978 $368K
97803 6,009 5,463 $368K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 21,576 19,969 $367K
76770 3,370 3,191 $367K
84443 Thyroid stimulating hormone (TSH) 41,577 40,367 $367K
52000 518 507 $365K
77067 Screening mammography, bilateral, including computer-aided detection 12,336 12,172 $341K
76830 Ultrasound, transvaginal 4,001 3,865 $336K
97161 6,793 6,386 $322K
76642 3,270 3,130 $304K
G0378 Hospital observation service, per hour 10,876 4,839 $302K
83036 Hemoglobin; glycosylated (A1C) 57,088 55,110 $300K
31575 1,447 1,379 $292K
71275 Computed tomographic angiography, chest, with contrast material 2,204 2,079 $290K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 305 302 $290K
71250 5,618 5,296 $290K
J2357 Injection, omalizumab, 5 mg 172 113 $279K
J3490 Unclassified drugs 9,976 7,934 $268K
95886 1,546 1,447 $262K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6,185 5,757 $255K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 9,358 9,024 $254K
71046 Radiologic examination, chest; 2 views 22,093 20,408 $248K
70551 Magnetic resonance imaging, brain; without contrast material 1,427 1,347 $248K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 9,289 8,955 $247K
76536 2,328 2,270 $244K
95811 363 341 $235K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 188 187 $235K
71260 Computed tomography, thorax, diagnostic; with contrast material 3,629 3,391 $231K
31231 1,002 952 $219K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 846 821 $216K
S9485 Crisis intervention mental health services, per diem 380 333 $214K
80048 Basic metabolic panel (calcium, ionized) 62,449 53,571 $213K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 57,852 50,302 $210K
82607 24,883 24,168 $209K
80061 Lipid panel 56,974 54,959 $203K
80050 General health panel 10,084 9,703 $202K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 190 180 $197K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 16,060 12,916 $193K
85027 54,897 48,753 $190K
J0178 Injection, aflibercept, 1 mg 438 405 $190K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 345 322 $189K
17110 1,073 1,025 $187K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 20,182 17,700 $181K
92340 Fitting of spectacles, except for aphakia; monofocal 6,383 4,633 $179K
77080 3,291 3,246 $173K
94060 2,641 2,495 $166K
82728 21,716 20,752 $162K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 6,617 6,534 $157K
93321 947 908 $154K
92557 3,183 3,052 $145K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 12,384 11,755 $143K
84484 18,194 15,402 $143K
77065 Tomosynthesis, mammo 1,961 1,791 $139K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 4,764 4,729 $136K
77066 Tomosynthesis, mammo 1,633 1,600 $136K
84466 19,984 19,143 $136K
87631 2,119 2,008 $131K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 106 106 $129K
73221 562 529 $129K
93351 1,082 1,036 $128K
86480 3,120 3,012 $124K
72141 690 668 $124K
84702 11,199 10,154 $122K
93017 1,701 1,618 $117K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,978 1,716 $115K
84153 8,806 8,519 $115K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 580 460 $115K
90686 5,738 5,570 $110K
83970 6,584 6,202 $108K
88305 Level IV - Surgical pathology, gross and microscopic examination 15,649 14,755 $108K
86803 10,659 10,379 $108K
83735 36,447 25,893 $106K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 2,330 1,206 $105K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 5,653 5,441 $102K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3,931 3,793 $101K
97802 1,402 1,331 $100K
92134 9,741 9,087 $96K
64493 120 106 $95K
83880 6,677 6,037 $92K
84403 5,783 5,566 $91K
93325 1,526 1,446 $91K
90750 1,001 997 $89K
85610 46,886 34,519 $89K
0011A 3,168 3,066 $84K
95117 1,917 1,098 $82K
94010 2,316 2,200 $82K
86140 25,148 22,956 $80K
87086 Culture, bacterial; quantitative colony count, urine 18,759 16,703 $75K
J1644 Injection, heparin sodium, per 1000 units 6,472 3,305 $74K
ATP14 12,606 10,989 $74K
73562 7,118 6,508 $74K
73130 5,932 5,158 $73K
90715 3,106 2,972 $73K
J7030 Infusion, normal saline solution , 1000 cc 23,345 15,328 $72K
83540 20,294 19,449 $71K
73630 7,667 6,510 $70K
Q3014 Telehealth originating site facility fee 26,832 23,005 $70K
94729 3,239 3,054 $70K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 527 522 $69K
90792 Psychiatric diagnostic evaluation with medical services 1,612 1,507 $69K
ATP08 12,889 10,832 $68K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 201 185 $68K
77336 1,127 501 $68K
99385 651 643 $68K
92083 3,038 2,877 $67K
0001A 2,433 2,246 $67K
81003 54,999 48,724 $67K
73030 6,854 6,090 $64K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2,144 1,975 $64K
99218 131 77 $63K
C9257 Injection, bevacizumab, 0.25 mg 1,930 1,780 $63K
11100 290 275 $61K
87522 Neg quan hep c or qual rna 1,906 1,818 $61K
84270 4,535 4,372 $61K
J2250 Injection, midazolam hydrochloride, per 1 mg 17,146 15,958 $60K
72100 3,396 3,275 $60K
83690 13,957 12,670 $59K
11900 256 248 $58K
96375 Therapeutic injection; each additional sequential IV push 14,223 11,859 $57K
17000 655 628 $56K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 94 61 $55K
92341 1,591 1,574 $55K
88342 3,292 2,934 $54K
73610 5,809 4,998 $54K
87088 11,916 10,976 $53K
49083 120 51 $53K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,569 923 $53K
62321 96 82 $52K
95018 432 427 $52K
0012A 1,813 1,793 $52K
86780 4,478 4,325 $51K
92133 3,945 3,798 $50K
82746 6,150 5,912 $49K
82784 5,005 4,621 $48K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 2,270 2,171 $48K
82105 5,826 5,379 $48K
G0297 Low dose ct scan (ldct) for lung cancer screening 728 720 $46K
87340 7,061 6,694 $46K
83516 3,744 3,435 $45K
84439 8,528 8,228 $43K
81025 7,990 7,484 $43K
86850 8,663 7,434 $42K
71271 982 964 $42K
86706 5,703 5,483 $41K
82043 17,461 15,392 $41K
90834 Psychotherapy, 45 minutes with patient 7,302 5,358 $40K
72125 Computed tomography, cervical spine; without contrast material 3,916 3,526 $40K
86618 2,694 2,612 $39K
93970 332 319 $39K
93296 1,558 1,488 $39K
51798 5,645 5,239 $38K
98968 513 461 $38K
73110 4,351 3,546 $38K
86038 4,757 4,515 $38K
86704 4,782 4,582 $38K
73502 4,107 3,878 $37K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 2,885 2,741 $37K
87102 5,914 5,628 $36K
74178 193 187 $35K
82670 1,711 1,664 $35K
71045 Radiologic examination, chest; single view 8,706 7,613 $35K
ATP15 6,071 4,876 $34K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 343 337 $33K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,210 3,084 $33K
83001 2,372 2,311 $32K
86900 9,227 7,705 $32K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 5,128 2,982 $32K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 2,460 2,310 $32K
80076 9,927 9,394 $32K
94726 690 657 $31K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 233 208 $31K
0002A 1,000 990 $31K
82248 24,957 22,014 $31K
87081 6,778 6,484 $31K
80197 8,279 5,428 $30K
70486 278 261 $28K
82274 1,755 1,754 $28K
82565 10,506 9,956 $28K
85379 4,505 4,249 $27K
77002 1,164 1,092 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 776 730 $27K
87186 6,620 6,075 $27K
96367 181 128 $27K
83605 4,255 3,503 $27K
72197 100 93 $27K
82330 6,891 6,429 $27K
87205 9,113 8,489 $26K
97035 496 231 $26K
82570 11,800 9,914 $26K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 86 82 $25K
87634 550 535 $25K
86160 1,862 1,763 $25K
0064A 983 944 $25K
70496 200 186 $24K
95885 146 141 $24K
86901 9,174 7,657 $24K
91322 349 346 $23K
84146 1,540 1,486 $23K
95024 135 135 $22K
72040 1,114 1,071 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg 17,904 14,503 $22K
95810 Polysomnography; sleep staging with 4 or more additional parameters 24 24 $22K
J3010 Injection, fentanyl citrate, 0.1 mg 16,196 15,006 $22K
84100 27,111 19,308 $22K
ATP17 7,997 7,050 $21K
99386 216 214 $21K
83002 1,449 1,412 $21K
90791 Psychiatric diagnostic evaluation 1,774 1,563 $21K
95910 155 154 $20K
92567 3,395 3,258 $20K
95813 59 54 $20K
87077 4,875 4,467 $20K
88112 599 564 $20K
36415 Collection of venous blood by venipuncture 99,039 80,262 $20K
86200 2,211 2,147 $20K
97165 250 236 $19K
A9585 Injection, gadobutrol, 0.1 ml 11,287 10,504 $19K
J2704 Injection, propofol, 10 mg 17,344 14,456 $19K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 369 173 $19K
84550 19,220 14,830 $18K
74018 1,549 1,363 $17K
87040 1,999 1,734 $17K
64635 54 51 $17K
73080 1,585 1,410 $17K
90662 2,728 2,647 $17K
84165 3,491 3,351 $17K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 205 195 $16K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 52 37 $15K
90677 649 626 $15K
83721 2,667 2,604 $15K
20553 88 83 $15K
99443 507 438 $15K
83921 1,225 1,186 $15K
ATP16 2,299 1,656 $15K
87070 3,286 2,962 $15K
20550 79 69 $15K
88307 306 296 $14K
77334 122 86 $14K
76882 126 121 $14K
76981 322 316 $14K
87147 1,681 1,520 $14K
85730 4,793 4,437 $14K
99442 814 665 $14K
G0444 Annual depression screening, 5 to 15 minutes 6,784 6,551 $14K
84480 1,385 1,344 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg 13,831 11,617 $13K
64494 76 52 $13K
86334 1,193 1,162 $13K
J0690 Injection, cefazolin sodium, 500 mg 6,628 5,472 $13K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 8,400 6,921 $12K
36591 3,466 2,113 $12K
86431 2,890 2,803 $11K
99441 189 178 $11K
77062 123 122 $11K
73564 1,645 1,540 $11K
0004A 472 442 $11K
11721 765 708 $11K
83883 971 906 $11K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 112 111 $10K
84425 672 657 $10K
90732 544 528 $10K
82962 17,318 12,503 $10K
86235 101 94 $10K
94761 18,543 16,514 $10K
88304 1,286 1,249 $9K
95819 52 52 $9K
87497 1,205 869 $9K
J1650 Injection, enoxaparin sodium, 10 mg 2,045 752 $9K
J1170 Injection, hydromorphone, up to 4 mg 5,984 4,074 $9K
82550 4,773 4,380 $9K
86708 912 862 $9K
97162 158 152 $9K
93225 123 121 $9K
64405 29 26 $9K
85014 6,273 5,774 $9K
88341 386 334 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg 4,014 3,170 $8K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 45 45 $8K
G0008 Administration of influenza virus vaccine 4,071 3,934 $8K
83718 1,335 1,314 $8K
83520 556 526 $8K
91301 2,540 2,389 $8K
11104 13 12 $8K
90670 276 259 $8K
90480 353 350 $8K
85018 3,271 2,818 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,649 2,482 $7K
83521 912 819 $7K
82390 865 850 $7K
ATP03 9,275 7,846 $7K
58300 24 24 $7K
76870 41 40 $7K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 46 36 $7K
84460 5,610 5,345 $7K
0054A 191 186 $7K
84450 4,853 4,630 $7K
82150 1,213 1,146 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 7,030 6,487 $6K
J7120 Ringers lactate infusion, up to 1000 cc 3,180 2,607 $6K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 2,332 2,089 $6K
64636 107 51 $6K
0124A 245 236 $6K
89051 1,830 995 $6K
57454 14 14 $6K
82040 4,082 3,788 $6K
99201 38 38 $6K
90472 Immunization administration, each additional vaccine (list separately) 687 673 $5K
86769 210 192 $5K
97804 84 83 $5K
0134A 230 227 $5K
87799 1,140 688 $5K
90832 Psychotherapy, 30 minutes with patient 1,840 1,578 $5K
84156 3,431 3,124 $5K
99205 Prolong outpt/office vis 104 99 $5K
ATP11 2,062 1,839 $5K
86812 230 228 $5K
ATP07 1,248 1,102 $5K
84134 419 405 $5K
82172 325 319 $4K
81015 1,993 1,909 $4K
77061 51 50 $4K
74246 28 27 $4K
84630 458 454 $4K
83615 2,663 2,367 $4K
86364 685 674 $4K
86765 250 234 $4K
82985 570 546 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 3,145 3,111 $4K
46600 69 66 $4K
90853 Group psychotherapy (other than of a multiple-family group) 190 89 $4K
82610 604 560 $4K
82525 383 370 $4K
51702 1,065 955 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,367 1,693 $4K
96376 1,688 1,423 $4K
99406 312 290 $4K
80164 1,541 1,413 $3K
J1815 Injection, insulin, per 5 units 1,139 405 $3K
96910 75 12 $3K
ATP18 1,610 1,422 $3K
93226 52 52 $3K
98967 56 48 $3K
86355 281 267 $3K
87427 144 139 $3K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 704 690 $3K
87517 122 117 $3K
82533 241 222 $3K
86255 339 310 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 20,967 18,932 $3K
83090 208 207 $3K
84590 311 309 $3K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 26 26 $3K
J2060 Injection, lorazepam, 2 mg 2,780 1,983 $3K
86225 356 336 $3K
84207 124 123 $3K
86695 117 114 $3K
86787 199 180 $3K
J2270 Injection, morphine sulfate, up to 10 mg 3,985 3,243 $3K
72202 82 82 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,375 1,250 $3K
70498 113 103 $3K
81002 1,757 1,552 $2K
C1769 Guide wire 1,500 1,378 $2K
86696 104 102 $2K
92285 438 414 $2K
84446 220 214 $2K
86381 129 125 $2K
87486 86 82 $2K
87581 86 82 $2K
83037 614 603 $2K
91300 1,758 1,594 $2K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 59 58 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 13 12 $2K
ATP09 493 377 $2K
0003A 136 135 $2K
86735 70 68 $2K
86147 41 41 $2K
94760 12,421 11,174 $2K
0296T 43 42 $2K
93880 53 51 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 4,249 4,032 $2K
90656 121 120 $2K
93299 25 25 $2K
86762 71 68 $2K
J1630 Injection, haloperidol, up to 5 mg 1,376 1,134 $2K
76942 377 352 $2K
86376 94 93 $2K
73590 517 439 $2K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 608 582 $1K
J1040 Injection, methylprednisolone acetate, 80 mg 4,129 3,932 $1K
87046 143 139 $1K
73140 219 213 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 20,513 17,438 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg 9,095 6,466 $1K
J7050 Infusion, normal saline solution, 250 cc 404 385 $1K
82103 131 125 $1K
90746 25 25 $1K
92250 128 125 $1K
J1756 Injection, iron sucrose, 1 mg 28 13 $1K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 540 532 $1K
87269 69 66 $1K
72131 38 32 $1K
87045 142 138 $1K
86146 25 25 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,706 1,070 $1K
80178 434 393 $1K
82378 183 173 $1K
82947 309 307 $1K
ATP04 455 397 $1K
86800 65 65 $1K
86356 49 45 $992.04
ATP10 401 316 $959.51
87272 69 66 $932.74
J3475 Injection, magnesium sulfate, per 500 mg 377 263 $863.69
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 13 13 $818.60
G0009 Administration of pneumococcal vaccine 790 778 $798.13
J0780 Injection, prochlorperazine, up to 10 mg 500 433 $782.11
51705 60 58 $775.97
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 2,255 1,878 $734.38
J1071 Injection, testosterone cypionate, 1 mg 501 235 $728.32
86015 100 95 $715.07
96417 64 38 $712.07
73522 13 13 $708.66
87075 161 131 $698.01
86003 12 12 $671.70
86617 13 13 $650.87
82785 52 50 $636.59
J1030 Injection, methylprednisolone acetate, 40 mg 741 719 $634.48
99152 2,214 2,021 $615.30
88173 14 12 $612.83
86666 13 12 $586.05
82805 42 29 $555.84
88185 12 12 $544.76
72070 26 25 $542.64
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 274 260 $534.60
97116 74 43 $525.16
82977 168 166 $507.30
C9399 Unclassified drugs or biologicals 103 94 $505.96
83021 32 31 $484.12
86036 43 39 $476.50
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 5,566 4,221 $466.42
99492 133 132 $463.21
86328 16 12 $461.62
86359 25 25 $458.41
86357 25 25 $458.41
99153 Mod sedat endo service >5yrs 205 189 $457.97
ATP02 188 151 $418.26
82948 73 67 $417.24
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 1,204 1,183 $406.47
69209 13 12 $395.49
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 1,016 802 $381.92
82310 568 529 $367.85
0013A 99 99 $366.96
85045 233 210 $351.51
85705 42 42 $345.58
83020 32 31 $345.02
85613 42 42 $343.62
84481 14 14 $339.14
ATP13 195 175 $326.70
J8540 Dexamethasone, oral, 0.25 mg 791 413 $313.04
92136 120 109 $302.90
84520 819 766 $281.69
84132 390 276 $274.14
82627 13 12 $265.28
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 1,222 1,131 $257.17
86317 16 16 $237.96
93298 12 12 $237.05
86304 42 36 $235.95
87015 58 54 $225.07
ATP20 72 54 $223.82
73090 62 50 $218.26
86709 12 12 $205.77
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 12 12 $186.59
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 276 221 $186.30
85652 100 96 $160.45
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 2,437 1,828 $153.68
88312 14 13 $151.72
88313 54 52 $142.41
87338 14 14 $140.89
87207 13 13 $140.65
86308 25 25 $137.94
86711 32 29 $134.10
ATP19 77 61 $125.51
87324 12 12 $120.34
87449 12 12 $120.34
J3489 Injection, zoledronic acid, 1 mg 13 13 $111.89
82077 59 52 $110.06
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 319 196 $100.80
91306 228 225 $95.52
88184 12 12 $92.82
J2370 Injection, phenylephrine hcl, up to 1 ml 3,655 3,100 $74.17
72170 74 66 $73.55
85004 165 136 $73.37
86360 13 13 $70.95
80069 91 79 $70.69
73552 96 87 $69.04
80175 30 29 $54.68
99493 271 270 $52.68
72156 13 12 $44.82
71101 13 13 $35.10
73060 50 41 $28.49
J1020 Injection, methylprednisolone acetate, 20 mg 69 67 $15.25
80156 25 25 $15.03
80185 12 12 $13.67
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 758 746 $13.20
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 461 436 $11.81
J2765 Injection, metoclopramide hcl, up to 10 mg 403 353 $7.70
J1171 Injection, hydromorphone, 0.1 mg 62 33 $5.04
J1010 Injection, methylprednisolone acetate, 1 mg 256 235 $1.91
J7060 5% dextrose/water (500 ml = 1 unit) 49 25 $1.31
J0670 Injection, mepivacaine hydrochloride, per 10 ml 16 14 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 324 303 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 388 351 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 62 55 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 8,935 6,791 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 98 91 $0.00
91313 67 67 $0.00
J3370 Injection, vancomycin hcl, 500 mg 144 67 $0.00
51741 17 15 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 92 88 $0.00
76514 12 12 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 59 57 $0.00
92020 16 15 $0.00
C1780 Lens, intraocular (new technology) 110 104 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 28 25 $0.00
C9113 Injection, pantoprazole sodium, per vial 22 13 $0.00
91312 83 83 $0.00
90837 Psychotherapy, 53 minutes with patient 19 15 $0.00
94664 28 25 $0.00
99397 12 12 $0.00
82523 12 12 $0.00
J2785 Injection, regadenoson, 0.1 mg 100 88 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 190 170 $0.00
V2632 Posterior chamber intraocular lens 473 404 $0.00
G0442 Annual alcohol misuse screening, 5 to 15 minutes 55 55 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 52 50 $0.00
91305 55 53 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 14 13 $0.00
80177 13 12 $0.00
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 25 25 $0.00
C1726 Catheter, balloon dilatation, non-vascular 12 12 $0.00